RankingsPricing
  1. US-listed companies
  2. DYNAVAX TECHNOLOGIES CORP

DYNAVAX TECHNOLOGIES CORPDVAX

Market cap
$1.4B
P/E ratio
Back to summarized table
Income statementBalance sheetCash flow
Dec 31,
2011		Dec 31,
2012		Dec 31,
2013		Dec 31,
2014		Dec 31,
2015		Dec 31,
2016		Dec 31,
2017		Dec 31,
2018		Dec 31,
2019		Dec 31,
2020		Dec 31,
2021		Dec 31,
2022
Cash and cash equivalents3282350452427494032436202
Marketable securities available-for-sale---731515716596111133110422
Accounts receivables, net----------116-
Other receivables----------162
Inventory, Net------01941646159
Prepaid manufacturing---------29160-
Prepaid expenses and other current assets12142746797486
Total current assets12512819212720090198174209290973917
Property and equipment, net68981417171732313538
Operating lease right-of-use assets--------30272626
Goodwill223222222222
Restricted cash111111110000
Other assets000000153433
Total assets1341402051382171102192112793531,039986
Accounts payable222134559333
Accrued research and development---7754104355
CEPI accrual (Note 9)----------129108
Accrued liabilities (Note 7)810861511101615195031
Warrant liability--------151118-
Deferred revenue---------38350-
Other current liabilities-------710334
Total current liabilities27191620292019385377556150
Convertible Notes Payable----------220222
Long-term portion of lease liabilities--------38353433
Other long-term liabilities111110191360
Total liabilities34251838302019148271295817405
Common Stock, Value, Issued000000000000
Additional paid-in capital---6958909051,1081,1311,2291,3521,4421,511
Accumulated other comprehensive (loss)-1-1-0-2-3-4-1-2-20-2-5
Accumulated deficit-366-435-502-593-700-812-907-1,066-1,219-1,294-1,217-924
Total stockholders’ equity1001151861001878920063859222581
Total liabilities and stockholders’ equity1341402051382171102192112793531,039986